Drug Type saRNAs |
Synonyms- |
Target |
Mechanism factor VIIa agonists(Factor VIIa agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Ractigen TherapeuticsStartup |
Active Organization Ractigen TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Factor VII Deficiency | Preclinical | CN | Ractigen TherapeuticsStartup | 19 Aug 2024 |
Hemophilia | Preclinical | CN | Ractigen TherapeuticsStartup | 19 Aug 2024 |